Impact of P53 and SIRT1 in Type 2 Diabetes

Recruiting now · Phase 3

Conditions studied: DM

In brief

Investigating the impact of p53 and SIRT1 in the development of type 2 DM

Key facts

Study ID

NCT03925714

Run by

Sherief Abd-Elsalam

People needed

90

Starts

2019-04-01

Expected to finish

2028-12-01

Last updated by the study team

2019-04-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Prediabetic subjects.

You may not qualify if…

• Confirmed diabetes.
• Hepatic or renal impairment.

Where it is running

• Sherief Abd-Elsalam — Cairo, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.